VeriSign Valuation
Is VRSN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VRSN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VRSN * (MX$3142.72) is trading above our estimate of fair value (MX$3039.59)
Significantly Below Fair Value: VRSN * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VRSN *?
Other financial metrics that can be useful for relative valuation.
What is VRSN *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$17.44b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 12.1x |
Enterprise Value/EBITDA | 17.3x |
PEG Ratio | 5.9x |
Price to Earnings Ratio vs Peers
How does VRSN *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 59x | ||
GDDY GoDaddy | 12.6x | -3.4% | US$17.7b |
AKAM Akamai Technologies | 28.2x | 13.7% | US$15.5b |
300442 Range Intelligent Computing Technology Group | 28.3x | 28.7% | CN¥54.0b |
DCII DCI Indonesia | 166.9x | n/a | Rp86.7t |
VRSN * VeriSign | 20.9x | 3.5% | Mex$17.4b |
Price-To-Earnings vs Peers: VRSN * is good value based on its Price-To-Earnings Ratio (20.9x) compared to the peer average (59.6x).
Price to Earnings Ratio vs Industry
How does VRSN *'s PE Ratio compare vs other companies in the Global IT Industry?
Price-To-Earnings vs Industry: VRSN * is good value based on its Price-To-Earnings Ratio (20.9x) compared to the Global IT industry average (22.5x).
Price to Earnings Ratio vs Fair Ratio
What is VRSN *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 20.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate VRSN *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$3,667.66 0% | 7.8% | Mex$4,125.47 | Mex$3,429.32 | n/a | 4 |
Apr ’25 | Mex$3,142.72 | Mex$3,707.16 +18.0% | 7.3% | Mex$4,001.54 | Mex$3,326.30 | n/a | 4 |
Mar ’25 | n/a | Mex$3,814.55 0% | 7.4% | Mex$4,112.84 | Mex$3,418.82 | n/a | 4 |
Feb ’25 | n/a | Mex$3,887.45 0% | 6.0% | Mex$4,140.41 | Mex$3,613.83 | n/a | 4 |
Jan ’25 | n/a | Mex$3,883.33 0% | 6.2% | Mex$4,126.89 | Mex$3,602.03 | n/a | 4 |
Dec ’24 | n/a | Mex$3,925.51 0% | 6.7% | Mex$4,224.68 | Mex$3,621.16 | n/a | 4 |
Nov ’24 | n/a | Mex$4,096.60 0% | 6.3% | Mex$4,436.09 | Mex$3,802.37 | n/a | 4 |
Oct ’24 | n/a | Mex$3,910.75 0% | 5.3% | Mex$4,140.79 | Mex$3,578.46 | n/a | 4 |
Sep ’24 | n/a | Mex$3,910.75 0% | 5.3% | Mex$4,140.79 | Mex$3,578.46 | n/a | 4 |
Aug ’24 | n/a | Mex$3,849.23 0% | 5.6% | Mex$4,053.58 | Mex$3,503.09 | n/a | 4 |
Jul ’24 | n/a | Mex$4,414.07 0% | 6.0% | Mex$4,764.67 | Mex$4,045.48 | n/a | 4 |
Jun ’24 | n/a | Mex$4,414.07 0% | 6.0% | Mex$4,764.67 | Mex$4,045.48 | n/a | 4 |
May ’24 | n/a | Mex$4,414.07 0% | 6.0% | Mex$4,764.67 | Mex$4,045.48 | n/a | 4 |
Apr ’24 | n/a | Mex$4,614.62 0% | 6.7% | Mex$4,944.24 | Mex$4,197.94 | Mex$3,142.72 | 3 |
Mar ’24 | Mex$3,747.85 | Mex$4,614.62 +23.1% | 6.7% | Mex$4,944.24 | Mex$4,197.94 | n/a | 3 |
Feb ’24 | Mex$3,600.81 | Mex$4,827.20 +34.1% | 6.7% | Mex$5,235.50 | Mex$4,445.24 | n/a | 3 |
Jan ’24 | n/a | Mex$4,827.20 0% | 6.7% | Mex$5,235.50 | Mex$4,445.24 | n/a | 3 |
Dec ’23 | n/a | Mex$4,317.96 0% | 2.0% | Mex$4,406.09 | Mex$4,229.84 | n/a | 2 |
Nov ’23 | n/a | Mex$4,365.11 0% | 2.0% | Mex$4,454.19 | Mex$4,276.02 | n/a | 2 |
Oct ’23 | n/a | Mex$4,382.58 0% | 4.7% | Mex$4,586.42 | Mex$4,178.74 | n/a | 2 |
Sep ’23 | Mex$3,631.16 | Mex$4,382.58 +20.7% | 4.7% | Mex$4,586.42 | Mex$4,178.74 | n/a | 2 |
Aug ’23 | n/a | Mex$4,382.58 0% | 4.7% | Mex$4,586.42 | Mex$4,178.74 | n/a | 2 |
Jul ’23 | Mex$4,300.00 | Mex$4,182.34 -2.7% | 1.2% | Mex$4,231.54 | Mex$4,133.14 | n/a | 2 |
Jun ’23 | Mex$4,300.00 | Mex$4,182.34 -2.7% | 1.2% | Mex$4,231.54 | Mex$4,133.14 | n/a | 2 |
May ’23 | n/a | Mex$4,816.45 0% | 14.1% | Mex$5,775.66 | Mex$4,285.83 | n/a | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.